Lyell Immunopharma, Inc. (LYEL) stock forecast and price target
Price $14.30 · data as of November 13, 2026
12-month price target
Average target$37.62
Upside / downside+163.1%
Analysts8
ConsensusBuy
Low $12.00Average $37.62High $49.00
Gold marker: average target · white marker: today’s price ($14.30)
Analyst ratings
Strong buy 2Buy 5Hold 0Sell 0Strong sell 1
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-6.69 | — | $13860 |
| Next fiscal year ends December 31, 2027 | $-5.91 | +11.7% | $8780 |
| Next quarter ends December 31, 2026 | $-1.57 | — | $6710 |
| Quarter after ends March 31, 2027 | $-1.69 | — | $5000 |
Consensus of the analysts covering Lyell Immunopharma, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.
Frequently asked questions
What is the Lyell Immunopharma stock price target?
The average 12-month target from 8 analysts is $37.62, 163.1% above the current price of $14.30 Targets range from $12.00 to $49.00.
Is Lyell Immunopharma a buy according to analysts?
The consensus rating is “Buy” (2 strong buy, 5 buy, 1 strong sell). Ratings are opinions, not guarantees; this is not investment advice.
How much is Lyell Immunopharma expected to earn?
Analysts expect EPS of $-6.69 for the fiscal year ending December 31, 2026 and $-5.91 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.